Women’s gynaecological and reproductive health in UK nephrology: gaps in confidence, training and service delivery from a UK National Survey Authors: Anna Harrison, Mohammed Awais Hameed, Nadia Sarween, Jyoti Baharani Published: 2026 ABSTRACT ABSTRACTBackgroundWomen with chronic kidney disease (CKD) face unique gynaecological and reproductive health challenges, including menstrual and menopausal disturbances, fertility issues, and increased pregnancy-related risks. Despite the clinical relevance of these issues, it is unclear how well equipped nephrologists are to address them in routine practice.MethodsWe conducted a national cross-sectional survey of UK nephrologists and renal trainees to assess their confidence, clinical experience, and perceived barriers in managing women’s health within the context of CKD. The survey captured responses on a range of topics, including menstrual health, contraception, and pregnancy counselling.ResultsA total of 147 responses were received. Most respondents reported low confidence in managing menstrual disorders, menopause, and sexual dysfunction, with only a minority feeling comfortable addressing these issues. Confidence was modestly higher for contraception and pregnancy counselling, but fewer than half of respondents felt adequately prepared to adjust teratogenic medications or provide breastfeeding advice. Commonly cited barriers included time constraints, lack of formal training, and limited clinical exposure—particularly in managing pregnancy in dialysis patients, which most encountered rarely. Variability in service delivery was also noted, with some centres offering dedicated nephrology–obstetrics clinics, while others relied on fragmented care pathways.ConclusionsThere are significant gaps in training, confidence, and service provision for women’s health in UK nephrology practice. Addressing these gaps requires the integration of reproductive health into nephrology education, improved multidisciplinary service models, and clearer delineation of nephrologists’ roles in gender-specific care. These changes are essential to improve outcomes and ensure equitable, patient-centred care for women with CKD. What was known: Despite growing inclusion of women’s unique healthcare needs, there is acknowledgement that these are inadequately addressed within routine clinical practice. Despite growing inclusion of women’s unique healthcare needs, there is acknowledgement that these are inadequately addressed within routine clinical practice. This study adds: This national survey of UK nephrologists demonstrates gaps in confidence, training, and service provision, which act as barriers to providing comprehensive care. This national survey of UK nephrologists demonstrates gaps in confidence, training, and service provision, which act as barriers to providing comprehensive care. Potential impact: Educational and structural reforms are required, inviting further examination to provide equitable care within nephrology and improve the outcomes for women with chronic kidney disease. Educational and structural reforms are required, inviting further examination to provide equitable care within nephrology and improve the outcomes for women with chronic kidney disease. BACKGROUND Women make up approximately half of the world’s population and they face unique challenges when it pertains to their health as they experience the physiological and emotional changes associated with menstruation, pregnancy and childbirth, and menopause. Despite increasing societal inclusivity and a growing focus on women’s health, many women continue to report that their health needs remain inadequately addressed [1]. Furthermore, gaps persist in clinical expertise and confidence within the medical profession in managing female-specific health concerns [1]. Worldwide, women are more likely to have chronic kidney disease (CKD) than men [2, 3]. Women with CKD often face emotional and psychological hardship, and it has potential to affect their relationships, sexual health, and ability to conceive [4]. Additionally, menstrual abnormalities and early menopause are prevalent in women with CKD. Abnormalities of the hypothalamic–pituitary–ovarian axis, a relative lack of oestradiol, and increased prolactin levels are appreciated contributing abnormalities. [5–7]. Recent consensus statements and reviews have further synthesized the bidirectional relationship between CKD and menopause and the broader reproductive-health needs of women across the CKD lifespan [8–10]. Additionally, sexual dysfunction is also common, though often under-recognized [4, 5]. Importantly, menstrual and reproductive disorders are linked to adverse health outcomes, including increased risks of osteoporosis, cardiovascular disease, and reduced life expectancy [11–14]. These complications are already common in individuals with CKD, thereby likely compounding the overall risk of poor health outcomes in this population. Routine contraception counselling is essential for women with CKD, notably those with systemic disease or receiving medications with teratogenic potential. Careful consideration must be given to the type of hormonal contraceptive used, with attention to renal function, cardiovascular risk, and potential drug interactions. Oestrogen-containing contraceptive pills have been associated with adverse effects that may exacerbate underlying kidney disease, including hypertension, proteinuria, and an increased risk of thromboembolic events, partly mediated through activation of the renin–angiotensin–aldosterone system [5, 15]. Progestin-only options and non-hormonal methods should be considered. Consequently, nephrologists must weigh the benefits and risks of each contraceptive option and be equipped to counsel on these options. Though conception can be achieved during all stages of CKD, fertility is reduced and worsens with advancing CKD [16]. CKD is associated with higher risk pregnancies and adverse maternal and foetal outcomes [17–19]. Counselling, careful planning, and monitoring are required with an aim to mitigate these outcomes. The 2019 UK Clinical Practice Guideline on pregnancy and renal disease includes pregnancy counselling by a multidisciplinary team for the optimization of maternal health prior to conception [20]. Optimal timing for pregnancy in women with CKD includes achieving control of underlying systemic disease, ensuring stable renal function, and, for transplant recipients, deferring conception until at least 1-year posttransplant to reduce the risk of maternal and graft-related complications. Treatments such as mycophenolate mofetil and cyclophosphamide used to treat systemic renal diseases are known to be teratogenic, as are angiotensin-converting enzyme inhibitors, which may be contributing to blood pressure control for maternal health optimization. Careful consideration and adjustment of these medications necessitates a structured approach with vigilant monitoring, given the potential for disease flares and deterioration in renal function. Nephrologists routinely care for women across multiple stages of kidney disease, including those with progressive CKD, transplant donors and recipients, and patients requiring dialysis. Evidence suggests that many nephrologists have limited engagement with women’s health issues and report a lack of confidence in addressing reproductive and gynaecological concerns within the context of kidney disease care [21]. The Women’s Health Strategy for England policy paper explored the disparities faced by women and highlights the need to educate healthcare providers in women’s health matters [1]. This study aimed to evaluate the confidence of UK nephrologists and trainees in addressing and managing women’s health issues, the frequency with which these topics are discussed in routine clinical practice, and the perceived barriers to delivering comprehensive care for women with CKD. Findings from this work may inform the development of targeted educational initiatives and training curricula to enhance the competence of nephrologists in managing female-specific health concerns as part of routine kidney care. MATERIALS AND METHODS An original, 23-item online survey was developed by the authors using Google Forms. Given that no validated instrument existed, the survey questions were based on a comprehensive review of qualitative and quantitative studies related to women’s health in the context of CKD, including surveys published evaluating nephrologists’ practices with regard to managing these conditions [21–23]. The survey aimed to evaluate the experiences, clinical practices, and confidence levels of UK nephrologists and renal trainees in addressing women’s health issues. The survey content was structured around three key domains: participant demographics and training background; participant demographics and training background; current clinical practices; current clinical practices; confidence in addressing specific issues. confidence in addressing specific issues. Question formats included Likert scales, multiple-choice questions, and free-text responses to allow for both quantitative and qualitative analyses. The survey questions were formulated, then reviewed by the authors for relevance and clarity. It was not, however, forwarded for an independent review of validity or pilot tested. Ethics committee approval was not sought given that the survey was anonymous and completing the survey was optional, informing implied consent from respondents. Confidence was captured as a single, self-reported rating on a five-point Likert scale (‘not at all confident’ to ‘very confident’) for each topic, reflecting global self-efficacy rather than separately quantifying its component drivers—namely, knowledge, practical skill, and system-level enablers such as time and access to specialist services. These components are instead examined through the parallel items on clinical exposure and perceived barriers, and are interpreted jointly in the Discussion section. As the instrument was developed de novo and was not pilot tested or psychometrically validated, its measurement properties have not been formally established; this is acknowledged as a limitation. The survey was disseminated nationally via multiple platforms, including the United Kingdom Kidney Association (UKKA) newsletter, regional training programme directors, the UK Renal Specialty Registrar Club, and through informal distribution using nephrology contacts, social media, and institutional mailing lists. Data collection occurred over an 8-month period, yielding a total of ‘147 responses’ from UK-based nephrologists and trainees. All responses were securely collected via Google Forms and reviewed by the study panel. There were no exclusion criteria for survey responses, and the incomplete surveys were also included in the analysis. Descriptive analysis was undertaken to identify trends across the three thematic domains and to inform strategies for improving clinical training and practice related to women’s health in nephrology. RESULTS Participant characteristics A total of 147 responses were collected from UK-based nephrologists and renal trainees. Respondents represented a broad range of ages, genders, ethnic backgrounds, training pathways, and clinical experience. Participants ranged in age from 25 to over 60 years with the most represented age groups being 31–35 years (24.5%, n = 36), followed by 36–40 and 41–45 years (both 17.7%, n = 26). In terms of gender, 52.4% (n = 77) of respondents identified as female. Most respondents identified as either Caucasian (51.0%, n = 75) or Asian (36.1%, n = 53). Of the 144 respondents, 70.8% (n = 102) had graduated from UK medical schools . Consultants constituted the largest group of respondents (57.8%, n = 85) and specialty trainees in their final 2 years of training constituted 23.1% (n = 34). With regard to reported years of clinical experience, 40.8% (n = 60) of participants had >20 years of experience. Although 31–35 years was the most common age band, respondents were otherwise distributed across the older age groups, and the cohort overall was weighted towards senior, experienced clinicians; age, training grade, and years in practice therefore describe distinct dimensions of the sample rather than conflicting findings. No formal dataset exists in the UK to reflect the demographics of the Nephrology physician workforce, so it is not certain whether this is a representative sample. Current clinical practices The survey aimed to assess current clinical practices among UK nephrologists in managing women’s health concerns in the context of CKD (Fig. 1). Over the preceding 12 months, 43.4% of respondents (n = 63) reported counselling fewer than five women with CKD on menstrual issues, while 53.1% (n = 78) had counselled fewer than five patients regarding menopausal symptoms. Notably, 9% (n = 13) indicated they had never encountered a patient with menstrual concerns, and 7.6% (n = 11) expressed discomfort in providing counselling on this topic. In comparison, 8.2% (n = 12) had not provided menopause-related counselling, and 12.9% (n = 19) reported feeling uncomfortable discussing menopause with their patients. Twenty-four respondents had counselled >10 patients on menstrual disorders in the previous year. Similar responses were found for menopause (17 respondents). Forty-six respondents had carried out preconception counselling. Experience with preconception counselling was more common: 30.6% (n = 45) had counselled 5–10 patients, while 31.3% (n = 46) reported having managed >10 such cases. In contrast, counselling around breastfeeding was less frequently reported with over half of the respondents (51.0%, n = 75) counselling fewer than five women on breastfeeding in the previous year, and 26.5% (n = 39) had not provided breastfeeding-related guidance at all. Only a minority of respondents reported substantial experience in managing pregnancy among women with CKD. Overall, 26.5% (n = 39) had managed between 5 and 10 such patients, and 13.0% (n = 19) had managed >10. When asked to reflect on their cumulative career experience with pregnant patients requiring dialysis, 67.4% (n = 99) reported managing fewer than three cases, while 5.4% (n = 8) had managed >11. In addition, 70.1% (n = 103) reported managing <10 pregnant patients in non-CKD contexts, such as acute general medicine, over the previous year. The survey also examined current service provision for women with CKD who are planning pregnancy. Most respondents (78.5%, n = 113) reported working in centres offering formal preconception counselling. With respect to the clinical setting, 65.8% (n = 96) indicated that pregnancy planning was managed within a dedicated combined nephrology–obstetrics clinic. In contrast, 18.5% (n = 27) reported separate nephrology and obstetric clinics, 8.9% (n = 13) used the usual nephrology clinic, and 6.2% (n = 9) described management within a high-risk obstetrics clinic without formal renal input. Respondents were also asked about their exposure to and training in women’s health (Fig. 2). Of 145 respondents, the majority 69.0% (n = 100) reported receiving some form of structured teaching or formal lectures during their medical school or nephrology training. Clinical exposure was also identified as a key source of learning, with 64.8% (n = 94) citing outpatient encounters and 55.9% (n = 81) inpatient encounters. In contrast, a smaller subset of respondents (32.4%, n = 47) reported attending dedicated training courses or structured clinical placements. Within this group, 17.2% (n = 25) had undertaken a rotation in obstetrics and gynaecology, and 13.8% (n = 20) had undertaken a placement in general practice. A minority (9.7%, n = 14) described alternative learning opportunities, including participation in obstetric clinics, additional formal qualifications, or self-directed study. When asked about training experiences in women’s health, outpatient consultations (64.8% of respondents), inpatient consultations (55.9% of respondents), and lectures or formal teaching (69% of respondents) were the most common. NB. Multiple answers were allowed. Courses were also relatively common, with 32.4%. Rotations in general practice and obstetrics and gynaecology made up 13.8% and 17.2%, respectively. CONFIDENCE IN MANAGING WOMEN’S HEALTH The survey evaluated self-reported confidence among UK nephrologists in counselling and managing various aspects of women’s health (Fig. 3). Confidence was generally low in relation to menstrual disorders, with 62 respondents reporting they were ‘not at all confident’ and only 13 indicating confidence. A similar pattern was observed for menopause, where 132 respondents reported being ‘not confident’ or ‘somewhat confident’. Confidence in counselling on reduced libido was also limited: only 11 respondents reported confidence, while 134 reported little or none. Thirteen respondents were somewhat confident regarding menstrual disorders and none were very confident. Fifteen respondents were confident or very confident counselling on menopause, and 11 on decreased libido. More respondents reported feeling confident or very confident with contraception and preconception counselling (49 for both). The number feeling confident or very confident increased further for pregnancy/foetal outcomes (52 for both). Higher confidence was observed in domains relating to contraception and pregnancy. Forty-nine respondents reported being ‘confident’ or ‘very confident’ in providing contraceptive counselling, and 52 reported similar levels of confidence in pregnancy-related counselling, including foetal outcomes and optimal timing of conception in the context of kidney disease. Nonetheless, the majority in both areas continued to report low or only moderate confidence. More than half of respondents (51.4%, n = 75) reported feeling either ‘not confident’ or ‘somewhat confident’ in adjusting potentially teratogenic medications. In contrast, recognition of pre-eclampsia was identified as an area of relative strength: 56.1% (n = 82) reported being ‘confident’ or ‘very confident’ and only 4.1% (n = 6) described themselves as ‘not at all confident’. PERCEIVED BARRIERS TO PROVIDING WOMEN’S HEALTH CARE In a final two-part question, respondents were asked to identify perceived barriers to discussing and managing women’s health within routine nephrology practice (Fig. 4). The most frequently reported barriers included time constraints (n = 77), limited clinical experience (n = 76), and lack of knowledge (n = 72). Lack of awareness was also cited by 32 respondents. A total of 19 respondents indicated a belief that such discussions should occur in other specialty settings, while 10 reported concern that these conversations might be uncomfortable or embarrassing. Main barriers to managing women’s health issues in routine practice include: inexperience (52.1%) lack of knowledge (49.3%), and time constraints (52.7%). NB. Multiple selections allowed. Less than a quarter of respondents (21.9%) discuss routinely. Fear of embarrassment (physician or doctor) was reported by 6.8%. Thirteen percent of respondents felt it was under the remit of another specialty. Open-text responses (n = 17), analysed thematically, highlighted additional barriers including infrequent clinical encounters, limited patient initiation of these discussions, restricted access to specialist services, and inadequate prior training in women’s health during nephrology education. DISCUSSION This national survey provides novel insights into the current landscape of women’s health in UK nephrology practice, highlighting notable gaps in clinician confidence, service delivery, and training. It is increasingly recognized that women with CKD face distinct and often underappreciated challenges related to reproductive health, including altered fertility, menstrual and menopausal disturbances, increased pregnancy-related risk, and complications related to hormonal therapy [4, 5, 11, 15, 17–19]. Despite these well-documented associations, our findings suggest that nephrologists frequently feel underprepared to address these issues comprehensively in clinical practice. A central finding is the limited confidence nephrologists report in managing core aspects of women’s health. Most respondents lacked confidence in counselling on menstrual irregularities, menopause, and sexual dysfunction—conditions prevalent in CKD with implications for cardiovascular risk, bone health, and psychosocial well-being [11–14]. By contrast, greater confidence was reported in areas that more directly intersect with traditional renal care, such as contraception, pregnancy planning, and pre-eclampsia recognition. However, confidence remained suboptimal overall, with fewer than half of respondents expressing confidence in these domains. Notably, over half of respondents lacked confidence in adjusting potentially teratogenic medications in preparation for pregnancy or during breastfeeding. This is concerning, particularly given the importance of planned pregnancy in CKD, where maternal and foetal risks are significantly elevated, and medication teratogenicity is a real concern. These gaps may reflect the absence of formal training, limited clinical exposure, and a lack of structured inclusion of women’s health in the nephrology curricula. These challenges are compounded by the fact that many nephrologists encounter pregnancy in CKD infrequently, particularly in dialysis patients, which presents a major obstacle to developing clinical proficiency through experience alone. Importantly, these clinical uncertainties are not simply individual but are shaped by systemic limitations, as respondents identified time constraints, lack of formal training, and limited exposure as key barriers. Another important theme was role clarity and interprofessional boundaries. Nearly one in five respondents felt that women’s health issues—particularly contraception and menopause—should be addressed in general practice or by obstetrics/gynaecology services. While multidisciplinary collaboration is essential, this finding highlights potential gaps in accountability, which can result in fragmented care and missed opportunities for timely intervention. Nephrologists are uniquely positioned to provide integrated, disease-specific reproductive counselling. Thus, in summary, respondent confidence was potentially affected by factors operating at two distinct levels. At the individual level, gaps in formal knowledge and limited clinical exposure—particularly the rarity of pregnancy in dialysis, encountered only a handful of times across a career—constrain the development of proficiency. At the system level, clinic time pressures, the absence of structured women’s health content in the nephrology curriculum, and variable access to combined renal–obstetric services limit the opportunity to apply and consolidate that knowledge. Distinguishing these levels matters because each calls for a different remedy, as set out in our recommendations below. Service provision data revealed some encouraging findings: nearly two-third of respondents reported access to dedicated combined nephrology–obstetric clinics, indicating that effective models exist within the UK. However, a significant proportion of patients remain managed in siloed or nonspecialist settings, with potential consequences for variation in care quality and outcomes. The principal strength of this study is its national scope, capturing perspectives from a broad cross-section of UK nephrologists. It also addresses an underexplored area, providing baseline data on confidence, training, and service delivery. Limitations include the modest response rate. Authors of the paper specialize in obstetric nephrology and distributing to contacts subjects the survey to selection bias and could cause potential skewing of responses from those more familiar with managing women’s health issues. This likely overestimates the reflected confidence levels of respondents and the frequency with which these matters are discussed in routine clinical practice. Furthermore, there is likely an element of responder bias in this context. Without logs and data tracking, the true number of patients counselled/managed, recall bias may also have impacted the responses. Representativeness is difficult to assess because no formal registry of the UK nephrology physician workforce exists. Nonetheless, the broad spread of training grades (57.8% consultants and 23.1% senior trainees) and the near-even sex distribution (52.4% female) are broadly consistent with the recognized composition of the UK renal workforce, offering some reassurance, although formal statistical comparison was not possible. Self-reported confidence may not directly equate to competence, and regional variation in practice cannot be fully accounted for in this survey design. In summary, this survey reveals widespread gaps in confidence, training, and service provision related to women’s health in UK nephrology. These findings highlight an urgent need for educational and structural reform. First, integration of women’s health into the nephrology specialty curriculum and continuing professional development (CPD) should be prioritized, with use of simulation, case-based teaching, and joint training with obstetrics/gynaecology. Second, clearer definition of nephrologists’ roles within reproductive health pathways and wider adoption of joint renal–obstetric services are required to ensure consistent standards of care. Finally, professional societies such as the UKKA could support guideline development and decision aids to embed reproductive health within CKD management. Addressing these gaps is essential to improve health outcomes for women with CKD and to deliver equitable, gender-responsive renal care.